EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Er: YAG laser combined with botulinum toxin A for patients with local syringomas: A preliminary report

Bin Yao, Wenjun Chen, Shilei Wu, Qinhao Gu, Wei Feng iD

Journal of Cosmetic Dermatology · 2023

DOI: 10.1111/jocd.15800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2023. Verfasst von Bin Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Plastic & Reconstructive Surgery, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou…. Hauptthemen laut MEDLINE: Syringoma, Botulinum Toxins, Type A, Lasers, Solid-State, Laser Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Syringoma is a common but refractory benign skin tumor. Conventional treatment, such as ultra‐pulsed carbon dioxide (CO 2 ) laser or cryotherapy, often requires multiple treatment and can easily cause prolonged erythema, scarring, or depression, which are frustrating, so there is an urgent need to seek a safer and more effective method. In this article, we tried to demonstrate the Er:YAG laser combined with botulinum toxin A (BTXA) as a safer and more efficacious method for treating syringomas. Materials and methods: Twenty‐one patients with local syringomas were treated with erbium laser ablation. Immediately after laser treatment, approximately 10 units of BTXA were sprayed on the wound for 10 min.

Result

In total, 21 patients underwent 1.62 ± 0.74 treatments; their Periorbital Syringoma Severity Index (PSSI) score declined from 4.19 (before treatment) to 1.10 (after treatment), and the number of treatments was significantly lower than those reported in previous literature using the erbium laser alone.

Conclusion

The Er:YAG laser combined with botulinum toxin A for the treatment of syringoma is a safer and more effective treatment than traditional treatment methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SyringomaBotulinum Toxins, Type ALasers, Solid-StateLaser TherapySweat Gland NeoplasmsHumansErbium

Stichwörter der Autor:innen

Er:YAG laserbotulinum toxinlaser ablationsyringoma

Substanzen

Botulinum Toxins, Type AErbium

Autor:innen und Institutionen

  • Center for Plastic & Reconstructive Surgery, Department of Orthopedics, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
  • Hangzhou YiJia medical cosmetology clinic, Dermatology Department, Hangzhou, China.
  • Changshuo Street Health Center, Surgery Department, Huzhou, China.
  • Center for Plastic & Reconstructive Surgery, Department of Plastic & Reconstructive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.

ORCID-Profile: Wei Feng

Zitieren

APA

Yao, B., Chen, W., Wu, S., Gu, Q., & Feng, W. (2023). Er: YAG laser combined with botulinum toxin A for patients with local syringomas: A preliminary report. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.15800

Vancouver

Yao B, Chen W, Wu S, Gu Q, Feng W. Er: YAG laser combined with botulinum toxin A for patients with local syringomas: A preliminary report. Journal of Cosmetic Dermatology. 2023. doi:10.1111/jocd.15800

BibTeX
@article{Yao2023,
  author = {Yao, Bin and Chen, Wenjun and Wu, Shilei and Gu, Qinhao and Feng, Wei},
  title = {Er: YAG laser combined with botulinum toxin A for patients with local syringomas: A preliminary report},
  journal = {Journal of Cosmetic Dermatology},
  year = {2023},
  doi = {10.1111/jocd.15800}
}
Kostenlos starten →